Affordable prices without threatening the oncological R&D pipeline - An economic experiment on transparency in price negotiations

<p>This is the data repository of an economic&nbsp;experiment&nbsp;on the effects of transparency regulations, conducted by the Netherlands Cancer Institute and the University of Amsterdam. We replicated the EU pharmaceutical market in a laboratory setting. In a randomized-controlled study, we analyzed how participants, 400 students located in 4 European countries, negotiated in the current system of Price Secrecy in comparison to innovative bargaining settings where either prices only (Price Transparency) or prices and R&amp;D costs (Full Transparency) were made transparent to buyers.</p>